Identification of a clinical-grade maturation factor for dendritic cellsBOCCACCIO, Claire; JACOD, Sylvie; KAISER, Andrew et al.Journal of immunotherapy (1997). 2002, Vol 25, Num 1, pp 88-96, issn 1524-9557Article

Toll-like receptors in tumor immunotherapyPAULOS, Chrystal M; KAISER, Andrew; ANTONY, Paul A et al.Clinical cancer research. 2007, Vol 13, Num 18, pp 5280-5289, issn 1078-0432, 10 p., 1Article

Tumor-specific Th17-polarized cells eradicate large established melanoma. CommentaryBRONTE, Vincenzo; MURANSKI, Pawel; PTAK, Krzysztof et al.Blood. 2008, Vol 112, Num 2, issn 0006-4971, 214, 362-373 [13 p.]Article

Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T CellsWRZESINSKI, Claudia; PAULOS, Chrystal M; KAISER, Andrew et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 1-7, issn 1524-9557, 7 p.Article

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cellsBORKNER, Lisa; KAISER, Andrew; VAN DE KASTEELE, Willeke et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 8, pp 1173-1183, issn 0340-7004, 11 p.Article

Tumor-Specific CD8⁺ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsKERKAR, Sid P; MURANSKI, Pawel; MORGAN, Richard A et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6725-6734, issn 0008-5472, 10 p.Article

Type 17 CD8⁺ T cells display enhanced antitumor immunityHINRICHS, Christian S; KAISER, Andrew; PAULOS, Chrystal M et al.Blood. 2009, Vol 114, Num 3, pp 596-599, issn 0006-4971, 4 p.Article

Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2HEEMSKERK, Bianca; KE LIU; MORGAN, Richard A et al.Human gene therapy. 2008, Vol 19, Num 5, pp 496-510, issn 1043-0342, 15 p.Article

Genetic Engineering of Murine CD8⁺ and CD4⁺ T Cells for Preclinical Adoptive Immunotherapy StudiesKERKAR, Sid P; SANCHEZ-PEREZ, Luis; SCOTT, Christopher D et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 343-352, issn 1524-9557, 10 p.Article